MetWare
Wuhan
About MetWare
Maiwei Metabolism is a developer of novel medical metabolic technology, specializing in the use of cutting-edge metabolomics technology in the domains of life science research and medicine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $15.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2024)
- Website: metware.cn
- Phone: 027-62433042
Industries & Categories
Hospital, Medical, Wellness
Canonical: https://fsome.com/organization/metware-168219 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.